Viewing Study NCT07214961

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:04 PM
Ignite Modification Date: 2026-02-02 @ 10:44 AM
Study NCT ID: NCT07214961
Status: RECRUITING
Last Update Posted: 2025-12-22
First Post: 2025-07-21
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Sponsor: ARTBIO Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer (CRPC) View
None Metastatic Castrate Resistant Prostate Cancer (mCRPC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None radioligand therapy View
None Pb-212 View
None castrate-resistant prostate cancer View
None alpha particles View
None metastatic View
None mCRPC View
None Lu-177 View